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A group of molecules with the name diketopiperazines (DKP) are called so, because of 
their diketopiperazine ring as the core structural unit. Mainly there are 3 types of 
diketopiperazies which only differ in in the position of the keto group, one type has the 
keto groups in 2,3- position; another in 2,5-; and the third in 2,6- position. The 2,5- 
isomer has attracted great interest, because of compounds that have the same core 
structure unit occur in nature. One good example of such compounds that have been 
studied lately is Barettin. Since DKPs have some similarities to peptides and are 
biologically active natural products, like Barettin, studies in synthesis of DKP analogues 
have been performed to use DKP analogues to improve the metabolic properties of 
peptides. 
 
In this thesis, studies towards the synthesis of DKP analogues from the 2,5- isomer are 
described. The preparation of 2,5-diketopiperazine itself is described by two different 
methods. The first one is the more general approach and the second method is 
microwave assisted synthesis. Exploration of the use of Schöllkopf bis-lactime ethers in 
the synthesis of functionalized DKPs. The Schöllkopf ether was studied in a range of 
transformations through aldol condensation with aldehydes and ketones with various 
bases followed by dehydration.  
 
Both 2,5-DKP syntheses and alkylation were found to be successful whereas the aldol 
condensation step turned out to be a little bit problematic. Through the course of the 
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1H-NMR Proton nuclear magnetic resonance 
BuLi Butyl lithium  
DBU 1,8-Diazabicyclo[5.4.0]undec-7-ene 
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ESI Electrospray ionization 
GC-MS Gas Chromatography with Mass Spectrometry detector 
HRMS High Resolution Mass Spectrometry 
IR Infrared (spectroscopy) 
LDA Lithium diisopropylamide  
LiHMDS Lithium hexamethyldisilazane 
MeCN Acetonitrile  
MTBE Methyl tert-butyl ether 
MW Microwave 
NMR Nuclear magnetic resonance 
ppm Parts per million 
tBuOK Potassium tertbutoxide  
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
TLC Thin layer chromatography 
TMP Magnesium chloro 2,2,6,6-Tetramethylpiperidide Lithium Chloride Complex 
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1 Aims of the thesis 
DKPs are a group of molecules that have diketopiperazine ring as their core structural 
unit. There are three types of DKPs which only differ in the position of the keto-group. In 
this project out of all these three, the focus was only on the 2,5-isomer, simply because it 
is the core structure of the natural product Barettin. Barettin is a natural product that 
was isolated from the marine sponge Geodia barretti[1]. Below are structures of Barettin 
and of how a general analogue would look like.  
                
Figure 1. Barettin and the general structure of an analogue, R2 is anything in this case. 
 
There are many aspects of Barettin and its analogues that makes them so interesting. 
Foremost, studies have shown that Barettin has biological activity, which is a 
combination of anti-inflammatory and antioxidant activities [1]. This means that Barettin 
and its analogues with the same core structure, but different R2 group can be used in the 
development of potential drug candidates in various medicinal areas and purposes.  
When you attempt to synthesize new molecules while using a previously tested 
procedure with similar structure, it does not necessarily go as planned. So another 
reason to make these compounds is for the sake of finding out how to do it, and by 
finding out how to synthesize different analogues we can create a compound library 
which will give us an overview over which analogues are possible to make and those 
that are not, as well as which analogues may or may not have biological activity.  
The aims that were focused on and are presented in this project were: 
 Explore the use of Schöllkopf bis-lactime ethers in the synthesis of functionalized 
DKPs. 
 Can Schöllkopf bis-lactime ethers undergo aldoladdition or –condensation 
reactions? 
 What type of substrates can be used in the reactions? 




























Barettin is a natural product that has 2,5-diketopiperazine as its core structural unit 
with  arginine and tryptophan in 3,6 positions respectively. It was first isolated and 
described in 1986 from the marine sponge Geodia barretti that was harvested outside of 
Northern Norway. The molecular structure that was assigned to Barettin in 1986 is 
different than the one that was assigned later in 2002[2], but the molecule is in fact the 
same. This could be because of the equipment that was used in 1986, produced 
fragmentations of Barettin which led to misassigment of the correct structure. Figure 2 
presents these two structures. 
             
Figure 2. Structures of Barettin and from 1986 and 2002 respectively.  
 
Today it is known that Barettin is a biologically active compound. Barettin has shown 
strong antioxidant activity in biochemical assays as well as in lipid peroxidation assays. 
Later it was also found that Barettin has yet another function, namely it was able to 
inhibit the secretion of inflammatory cytokines IL-1  and TNF  from LPS-stimulated 
THP-1 cells. Therefore Barettin could be a possible drug candidate to prevent the 
development of atherosclerosis[1]. As usual, most organisms do not produce large 
amounts of a particular chemical at once, simply because it is not needed, and sponges 
like Geodia barretti is no exception. Unless organisms have been specially modified in a 
lab. Since large amounts of Barettin could not be extracted from the sponge due to many 
reasons, a more synthetic approach had to be developed on how to synthesize it in a lab. 
Today there are several methods on how to do it, and just to mention some of them are 
the Schöllkopf method and Horner–Wadsworth–Emmons type reaction.[30-32,34] 
 
2.2 Amino acids 
A large portion of our cells, muscles and tissues is made up of amino acids, and there are 
20 common amino acids. These amino acids have very important functions in the body 
like for example, they give the proper function to organs, gland, tendons and arteries. 
They are essential in repairing the body when it is damaged, they transport and store 
nutrient, giving cells their structure and many other functions which are no less 
important than others.[3]   
But at a given point in time there are not many free amino acids that just travel from 
place to place within the body, amino acids are mostly used for construction of proteins 
which carry out the functions described above. About 20% of a human body consist only 
of proteins. The construction of proteins happen in ribosomes, where mRNA that carries 
the specific codon for a particular amino acid and tRNA that carries the anticodon and 





Figure 3. General structure of an amino acid in its un-ionized form. The R-group is the 
characteristic side chain that separates amino acids. 
 
However, amino acids can also be synthesized in a lab and there are several way of 
doing it. Maybe one of the oldest methods is where you start by brominating the alpha 
carbon of a carboxylic acid. Then by using nucleophilic substitution with ammonia you 
can transform the alkyl bromide to the amino acid. Some other methods are the Strecker 
amino acid synthesis [4][5], where you treat an aldehyde with ammonia and potassium 
cyanide, which will give an -amino nitrile. Then by hydrolyzing the nitrile you can get 
the -amino acid. Other procedures with the use of asymmetric auxiliaries[6] or 
asymmetric catalysts[7] have been developed.  
 
2.3 The Schöllkopf method 
The Schöllkopf method or also commonly known as Schöllkopf bis-lactim amino acid 
synthesis is a method for the asymmetric synthesis of chiral amino acids that was 
established by Ulrich Schöllkopf in 1981[30-32]. This method involves the making of a 
dipeptide, cyclization, transformation of the keto groups into ethers, substitution of a 
glycine proton with something else and lastly breakage of the cyclization which is 
described more in detail below. The typical procedure involves a glycine as the substrate 
and a valine as the chiral auxiliary.  
Two amino acids bind together to form a cyclic dipeptide which is also known as 2,5-
diketopiperazine. An O-alkylation is performed with a Meerwein’s salt as the alkylating 
agent, which result in the bis-lactim ether. Then one of the glycine protons is removed 
by a base, usually an organometallic base. The carbanion then reacts with an alkyl halide 
and it seems that this is the decisive step for stereoselectivity of the whole method. One 
face of the carbanion is shielded by the isopropyl group of valine, which creates steric 
hindrance for the alkyl halide; this forces the alkylation to happen on the opposite side 
of the isopropyl group which gives this reaction strong preference for just one 
enantiomer[12-13, 30-32]. But then again, the stereoselectivity might also be influenced by 
the bulkiness of an alkyl halide, or an aldehyde if it is used instead. In the final step, 
there is a possibility to first go from bis-lactim ether back to DKP with the help of a weak 
acid; or to separate the two amino acids through an acid hydrolysis directly from bis-
lactim ether to form two amino acid esters with the help of a strong acid, as presented in 




Figure 4. Reaction pathway of the Schöllkopf procedure. 
 
2.3.1 Dipeptides 
When the amine group of one amino acid reacts with the carboxylic group of another 
amino acid they become joined through an amide linkage. This newly formed bond is the 
peptide bond. This type of polymerization of amino acid is how proteins are made. 
Figure 5 below presents the reaction mechanism of dipeptide formation.  
 




There is a common way to synthesize longer amino acid chain, the method is called 
solid-phase peptide synthesis. This method uses aromatic oxime derivatives (imines), 
Figure 6, of amino acid as activated units. These derivatives are added in a sequence 
onto the growing peptide chain, which is held together by a solid resin support system[8]. 
By varying the types and order of amino acids, with this method it is easily possible to 
synthesize long amino acid chains.  
 
Figure 6. General structures of oximes. An aldoxime and ketoxime respectively.  
 
2.3.2 Cyclization 
The name cyclization gives away what this topic is about, namely the cyclization of 
molecules. In short, there are many ways to make a cyclic compound, it all depends on 
what kind of molecule do you want to make cyclic. Like for example, there is the Nazarov 
cyclization for the synthesis of cyclopentenones,[9] the radical cyclization which goes 
through the formation of radical intermediates,[10] or the Diels-Alder reaction.[11]  
However, we are interested in another type of cyclization, namely the one presented in 
Figure 4, the cyclization of a dipeptide which is presented below in Figure 7. 
 
Figure 7. Reaction mechanism of the dipeptide cyclization into 2,5-DKP. Depending on 
which procedure is used, this reaction can be carried out in different solvents.[12][13] 
Some proton transfers are skipped in the figure. 
 
The mechanism presented in Figure 7 is the cyclization of the glycine-valine dipeptide. 
Depending on which procedure is used, this reaction can be carried out in different 
solvents.[12][13] But, this reaction method is not only applicable to glycine-valine 
dipeptides, it can also involve other amino acids.  
 
2.3.3 Diketopiperazine 
As mentioned earlier there are three isomers of diketopiperazine, one with the keto-
groups in 2,3-, another with keto-groups in 2,5- and the third isomer with keto-groups 
in 2,6- positions presented in figure 8. All of them can be found in nature through 




Figure 8. Diketopiperazine; 2,3-, 2,5- and 2,6-isomers.  
 
All of the three isomers are frequently used in medicine and although the structures are 
quite similar, the areas in which each isomer I used in, vary. The 2,3-isomer for example 
can be found in antibiotics such as piperacillin, cefoperazone and bicyclomycin 
presented in Figure 9.[14] 
   
 
Figure 9. Structures of piperacillin, cefoperazone and bicyclomycin respectively. 
 
The 2,5-isomer as described above is the core structure of Barettin which has some 
medicinal application. The 2,5-diketopiperazines has also other biological activities 
including  antifungal,[15] antiviral,[16] antitumor[17] and antibacterial[18] activities. In some 
biochemical synthesis this isomer is also frequently generated as degradation products 
in the syntheses of oligopeptides.[14] Another application is in commercialized drugs 
such as Tadalafil, Gliotoxin, Retosiban, Epelsiban and Aplaviroc. 
Lastly, the 2,6-isomer of DKPs has been of much interest in medicinal chemistry as 
antiproliferative agents through the inhibition of DNA topoisomerase II.[14] 
 
2.3.4 Bis-O-alkylation and dealkylation 
The idea behind bis-o-alkylation of diketopiperazines is quite simple if we look at the 
structure. First the nitrogen atoms would have to be deprotonated, the resulting 
structure will be stabilized by resonance. Now that we have negatively charged oxygens, 
an alkylation is possible with the appropriate reagent. The reagents can be for example 
alkyl halides of R-X type or Meerwein salts like Me3O+BF4-.[13] The mechanism is 




Figure 10. Reaction mechanism of bis-o-methylation. Reaction has only been shown on 
one side for simplicity.  
 
If we now want to go back, a possible dealkylation reaction might be something like 
treating the product from Figure 10 with an acid in water which will result in 
substitution where the methoxy-groups are exchanged with hydroxyl-groups. The 
resulting structure from this step is an isomer of the starting material. However, 
according to some studies that was performed,[19-21] if a strong acid such as HCl is used, 
then there is high chance to open the ring between nitrogen and carbonyl. While on the 
other hand, low concentrated TFA[20-21] or TMS-I[19] could be used to restore DKP from 
bis-lactim ether as shown in Figure 11. 
 
Figure 11. A possible reaction mechanism of the dealkylation process. The mechanism 
is shown only on one side for simplicity.  
 
2.4 Importance of different bases 
As one would expect, different bases have different strength and that makes them 
unique to one another, but all of them have a pH above 7. There is an enormous amount 
of different bases, everything from nonorganic, organic, inorganic, oxide mixtures and 
many other. The use of each base depends on how easily you can remove a proton that 
you want to remove, the more acidic and accessible the protons are in a molecule the 
easier is for them to be removed by a base.  
The relevant bases that are used in this project are mostly strong/super bases of the R-
Li+ type, BuLi, LiTMP, LDA and LiHMDS and RO- type, Cs2SO3 and K-tBuO-. Previously 
performed studies[19-23] have shown that these bases have the effect of deprotonation of 
diketopiperazines and other similar structures. The most important difference between 
these two types is the strength, R-Li+ are considered to be superbases and are stronger 
than RO- type of bases. Another difference that is worth to mention is how big or bulky 
each of these bases are. This difference is only relevant in some cases and the reason for 
that is, it all depends on how easily the protons are accessible in a molecule. For 





Figure 12. BuLi, LiHMDS, LDA and LiTMP respectively. Note that LiHMDS exists only as 
a cyclic trimer and BuLi as a tetramer/hexamer. The structures above are a simple 
representations of those. 
 
2.5 Aldol addition or condensation 
An aldol addition reaction is where an enol or an enolate ion reacts with a compound 
that has a carbonyl group to form a -hydroxyaldehyde or -hydroxyketone depending 
on which starting material is used. If this product is reacted further with either acid or 
base, a dehydration would happen, and this is the condensation part of the reaction.  
 
Figure 13. Aldol addition reaction with aldol condensation as the final product under 
basic and acidic conditions. 
 
Studies have been performed on the use of various 2,5-diketopiperazines as the starting 
material in aldol condensation reactions.[22-23][25] The 2,5-DKPs used in those studies 
were more activated  by having an acetyl group on both nitrogen atoms. This 
modification would prevent the formation of enolate ions and thereby 
activating/making the CH2 protons more acidic, the base would easily remove one of the 
protons. Also by having an oxygen atom near the deprotonation site from an acetyl-
group is good, especially if an R-Li+ base is used, since the oxygen would coordinate the 
base.  
In this project we are using a bis-lactim ether similar to that in figure 10 , The difference 
is that we use an ethyl- instead of a methyl group. Studies[26-28] have shown that even 
without those acetyl groups on the nitrogen atoms the reaction still works, and the 
general procedure is very similar. Whether there are acetyl-groups on the nitrogen 
atoms or not it cannot be looked at from the perspective of a general aldol condensation 
reaction. Because unlike the general aldol condensation reaction where an enol reacts 
with a protonated carbonyl of an aldehyde under acidic conditions, an aldol 
condensation where bis-lactim ether is used instead of an enol, would have to be under 
basic conditions. Otherwise there is a chance that the ether oxygen would be protonated 
and fall off like in figure 11. The reaction mechanism of aldol condensation is presented 




Figure 14. A possible reaction mechanism of an aldol addition/condensation reaction 
between bis-lactim ether and an aldehyde. 
 
2.6 Alkylation 
An alkylation reaction involves the transfer of an alkyl group from one molecule to 
another. There are several ways in which an alkyl group can be transferred to another 
molecule and that is through a carbocation, carbanion, carbene or a free radical. There 
are many variants of alkylating agents, and to mention just some of them are organometallic compounds, alkyl halides, Meerwein’ salts and etc.; but, probably the 
most common way to do it is by using alkyl halides (R-X) as alkylating agents. Alkylation 
with alkyl halides usually happen with reagents that have the halogen atom is on either 
primary or secondary carbon atom, that way it would be more accessible for a 
nucleophile as shown in Figure 15. 
 
Figure 15. An alkylation reaction with a general alkyl halide as the alkylating agent. 
 
If one would like to react a 2,5-diketopiperazine with an alkyl halide[29] instead of an 
aldehyde, the reaction mechanism would pretty much be the same except for the 
condensation step that is present in the aldol condensation reaction in Figure 13. 
General reaction mechanism of a bis-lactim ether reacting with an alkyl halide is 
presented in Figure 16. 
 
Figure 16. Reaction mechanism for alkylation of DKP. 
23 
 
3 Results and Discussion 
3.1 Synthesis of the dipeptide (5) 
 
Scheme 1. Synthesis of Boc-N-valine-glycine-OMe (5) 
 
Synthesis of the dipeptide 5 was done by first reacting Boc-D-valine 4 with isobutyl 
chloroformate and triethylamine in dichloromethane. Then, after some time reacted 
with a mixture of glycine methyl ester, triethylamine and dichloromethane as described 
above in Scheme 1 and reported in literature.[12-13] Reaction gave a whitish solid 
product and recrystallization from cyclohexane resulted in pure white powder. The pure 
product was analyzed by 1H and 13C NMR, and spectra were in full agreement with 
reported data in literature.[12-13] The yield was 76%.  
Note that some of the product was lost during the workup due to accident, so the yield 
could be higher. 
 
3.2 Cyclization of the dipeptide (5) 
Cyclization of the dipeptide 5 was performed by two different syntheses. The first 
synthesis was the general conventional heating process, and the second synthesis 
involved cyclization in a microwave. The main differences between these two 
procedures are the reaction times and solvents in which the reactions were carried out, 
other than that the idea of cyclization of the dipeptide is the same. 
 
3.2.1 Cyclization of 5 by conventional heating.  
 
Scheme 2. Synthesis of 2,5-diketopiperazine (6) by conventional heating  
 
To synthesize 2,5-DKP 6, dipeptide 5 was mixed with 1,2-dichlorobenzene, heated and 
stirred overnight. Then cooled down, filtered, washed with TMBE and left to dry at room 
temperature, Scheme 2. This experiment was performed one more time, where some of 
the conditions were different, to make more of 2,5-DKP 6, and to see if it could be 
possible to increase the yield. Reaction conditions and results are presented in Table 1. 
Table 1. Different reaction conditions and results for synthesis of (6). 




Entry Temperature Reaction 
time 
Crude yield 
a 172oC 20-21 hours 35% 
b 151oC 20-21 hours 30% 
 
 
The yield for conventional heating reaction reported in literature[13] is 69%, while the 
yields from this reaction method was only 35%a and 30%b, which is almost twice as less 
of un-pure product. The 1H NMR spectra gave weak signals for the peaks, probably due 
to small amounts of stuff used in the analysis, but they were mostly the same. One peak 
at 2.10 ppm (m, 1H) reported in the literature[13] is especially difficult to see on my 
spectra since it overlaps with something else. The splitting of some signals (multiplets) 
reported in the literature are not consistent with what my analysis gave, [13] this might 
be because the product used for 1H NMR analysis was not pure. However the signals are 
in the same region with very similar ppm values.  
As for purification of the product, 2,5-DKP 6 from this reaction, it was decided to wait 
until more was synthesized, and until synthesis of 6 was performed with microwave. 
Since the microwave synthesis gave better results, the product from this reaction 
method was never purified.   
 
3.2.2 Cyclization of 5 by microwave irradiation 
 
Scheme 3. Synthesis of 2,5-diketopiperaznie (6) by microwave irradiation 
 
Dipeptide 5 was transferred to a special microwave vial with a magnetic stirring bar, 
filled with water, locked and run at 600 rpm, 150-170oC and for 15-60 minutes. After the 
reaction was done, the reaction mixture was cooled down to room temperature, and 
then water was evaporated on a rotary evaporator. The resulting product was a white 
solid, a recrystallization was attempted from EtOH:CHCl3 (3:1) to yield 28% pure 2,5-
DKP (6). This reaction was carried out additional times under different conditions for 
optimization and for synthesis of more compound (6). Table 2 below presents the 
details of conditions used and which results they gave. 
 





Entry Temperature Reaction time Crude yield 
a 150oC 15 minutes 28% 
b* 170oC 60 minutes 95% 
c* 160oC 2x30 minutes 96% 
d* 150oC 75 minutes 89% 
* is the syntheses after optimization, 
 
The procedure used in the literature did not work for me,[12] in the article it was 
reported a yield of about 75%, while when I used the same conditions I only managed to 
get 28%a. So, an optimization of the reaction had to be done. Optimization of the 
procedure was rather straight forward, dipeptide 5 was first put into the microwave and 
turn on for 30 minutes hold-time. A sample was then taken out and analyzed by 1H NMR, 
it was clear that there was still some unreacted starting material. The same was done 
after 15 more minutes and then again after another 10 minutes. After total of about 55 
minutes reaction time, 1H NMR analysis showed that pretty much everything of starting 
material was gone. Entries b-d show very good yields, even higher than that in 
literature.[12] The 1H and 13C NMR data were in full agreement with the published data. 
[12-13]  
There was a lot of problems in the attempts to purify DKP 6. The recrystallization from 
EtOH:CHCl3 (3:1) as described in the article[12] did not work. 1H NMR analysis showed 
that there was still small amounts of starting material and other impurities. This is 
probably due to insolubility of compounds 5 and 6 in EtOH:CHCl3. It was found that 
compounds 5 and 6 have a good solubility only in water, it was tried out and showed no 
success. Since 1H NMR analysis of the crude product 2,5-DKP (6) showed only small 
amounts of impurities, it was decided that it was good enough for the next step. 
 
3.3 O-Ethylation of the 2,5-DKP (6) to form the bis-lactim ether (7) 
 
Scheme 4. Synthesis of bis-lactim ether (7) 
 
Bis-lactim ether 7 was prepared by reaction between DKP 6 and a solution of Et3O+BF4- 
in 1M methylene chloride, in the presence of CH2Cl2 as solvent, Scheme 4. This reaction 
was run several times and none of them gave good results. Even though 1H NMR 
analyses of the crude products showed the characteristic signals for bis-lactim ether 7, 
They were in such small amounts, that the column chromatography purification always 
gave bis-lactim ether 7 with impurities. Mostly, those impurities were either ethylation 
only on one side and ring opening. 
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The reagent used in this reaction is very sensitive to moisture in the air, and since the bottle with the chemical wasn’t that new, it was thought that the reagent was mostly 
destroyed. A miscalculation in the amounts of Et3O+BF4- solution needed for the 
reaction, might have been the cause of bad results. Note that this was not noticed when 
the reactions were performed, and since this reaction was attempted several times, this 
error is in all of them. As a result a new bottle of Et3O+BF4- in its solid form was used 
instead.  
The reaction procedure for the reagent Et3O+BF4- in its solid form is exactly the same 
and follows Scheme 4. These reactions produced far better results, whether the reasons 
for that was due to a completely new reagent or the correct calculations is uncertain, but 
most likely both. After the synthesis and purification of bis-lactim ether 7, 1H and 13C 
NMR analyses were run and the spectral data was consistent with the literature data.[12-
13] Purification was done by silica gel column chromatography with pentane:EtOAc 
(95:5) used as solvent that gradually increased in polarity after a while. Several 
reactions have been performed, Table 3 below presents the conditions and results.  
 
Table 3. Different reaction conditions and results for synthesis of (7). 
 
Entry Temperature Reaction 
time 
Yield 
a R.T. 144 hours 27% 
b 30oC 72 hours 48% 
c 30oC 70 hours 43% 
d 30oC 72 hours 47% 
e 30oC 72 hours 45% 
 
Note that entry a was the first reaction, hence the low yield. In entries b-e some portions 
of the product was lost in purification. All yields represent pure bis-lactim ether 7. 
 
3.4 Aldol condensation and alkylation reactions of (7) with different bases.  
The reactions between bis-lactim ether (7) and aldehydes/alkyl halides with different 
bases are described below. All the reactions were carried out in dry equipment and 
under nitrogen gas. Reactions between 2,5-DKPs, bis-lactim ethers and aldehydes as 
well as alkyl halides have been reported,[26-29,33] but in all those reactions the DKPs had 
had additional substrates on both nitrogen atoms and/or one of the glycine protons 
were substituted with a halogen before it was reacted with an aldehyde. However the 
focus in this project was only the reaction between bis-lactim ether 7 and aldehydes, 
and an alkyl halide just for testing. The exact reactions that are described below have 
not been reported earlier. Reactions under similar conditions are grouped together and 
summarized in Tables 5 and 6. All of the possible reaction products from aldol addition, 




Figure 17. A summary of all possible products from the different reactions.  
 
In all aldol addition/condensation reactions that actually worked, it is observed that the 
major product is the addition product. This does make sense since most of the base is 
used up in aldol addition. To actually get the condensation product, more of the base should have been added to the reaction, but this wasn’t done. The general procedure 
used to make all of the compounds that are presented in Figure 17 was the same and 
will only be described once. The differences between these reactions are the amounts of 
starting material used and the different bases, which are presented in sections 3.4.1 - 
3.4.11 and Schemes 5 – 14. 
 
Bis-lactim ether 7 was mixed together with dry DMF/THF, left either at room 
temperature or cooled down to -78oC and then a base was added. The reaction was then 
stirred for some time and then an aldehyde was added. The addition of bases and 
aldehydes was done slowly with syringes. After that the reaction was run either for 3 
hours or overnight under N2. All the reactions were monitored by TLC and from that 
decided either to stop or continue to reactions. In most of the reactions it was observed 
that THF evaporated, and the reaction mixtures became slimy or gel-like mixtures. This 
was solved by the addition of more dry THF. 
 
3.4.1 Synthesis of aldol addition 9 and condensation 10 products with Cs2CO3 as 
the base.  
 
Scheme 5. Synthesis of aldol addition 9 and condensation 10 products with Cs2CO3 as 
the base.  
 
TLC tests of the reaction mixture showed no differences and after 96 hours the reaction 
was stopped. 1H NMR and HRMS analyses of the crude product showed only the starting 
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material, decomposed starting material and benzaldehyde. It seems like Cs2CO3 base 
was not strong enough to take one of the glycine protons, so there was no reaction. 
 
3.4.2 Synthesis of aldol addition product 9 with k-tBuO/BuOH as the base. 
 
Scheme 6. Synthesis of aldol addition product 9 with k-tBuO/BuOH as the base. 
 
TLC showed some results, there was too many spots, so it was impossible to determine 
whether the reaction produced the wanted product or decomposition of starting 
material. 1H NMR and HRMS analyses of the crude product showed mostly starting 
material, decomposed starting material, benzaldehyde and very small amounts of 
compounds 9. In the HRMS spectra small amounts of aldol condensation product 10 was 
observed, but in 1H NMR there was nothing. Purification with silica gel column 
chromatography was attempted, but due to the very small amounts of the desired 
product, it could not be isolated and was lost in the purification.  
Another similar reaction was carried out, but this time DCM was not used and gave 
somewhat better results. In the 1H NMR and HRMS analyses of the crude, there was no 
more starting material and benzaldehyde, only different versions of the decomposed 
starting material and small amounts of aldol addition product 9, HRMS showed that 
aldol condensation product 10 was not present at all. Just as the previous reaction, we 
were unable to purify aldol addition product 9 due to very small amounts of it. There can be many reasons why these reactions worked so badly, whether the base just wasn’t 
strong enough or it reacted with bis-lactim ether in some other ways, but one thing is for 
sure is that k-tBuO/BuOH solution used in these reactions was quite old. Improvement 
of the reaction could definitely be something like increasing the reaction time and using 
more of the base. 
 
3.4.3 Synthesis of aldol addition product 9 with DBU as the base. 
 
Scheme 7. Synthesis of aldol addition product 9 with DBU as the base. 
 
TLC Showed that the starting material was not disappearing and there was no visible 
changes in the reaction mixture, so it was stopped after about 3 hours. 1H NMR and 
HRMS analyses of the crude product showed a lot of starting material, decomposed 
starting material, benzaldehyde and very little of aldol addition product 9. As we can see 
from the proton and mass spectra, the reaction was stopped prematurely and definitely 
required more reaction time, and probably even more DBU since it was more than 2 




3.4.4 Synthesis of aldol addition product 9 and aldol condensation product 10 
with BuLi as the base. 
 
Scheme 8. Synthesis of aldol addition product 9 and aldol condensation product 10 with 
BuLi as the base. 
 
This reaction was carried out twice under different conditions, Table 4 below presents 
conditions and results. 
 
Table 4. Different reaction conditions and results for synthesis of (9) and (10). 
 
Entry  Temperature Reaction time Yield 
a -78oC the whole 
time. 
1 hour after 
addition of BuLi, 
then 2 more hours 
after addition of 
benzaldehyde 
Below 1% of pure 
product. 
b -78oC for 2 hours at 
the start, then left 
in an open cooling 
bath starting at -
78oC which 
increased to RT. 
overnight  
1 hour after 
addition of BuLi, 
then 1 more hour at 
-78oC after addition 
of benzaldehyde. 
Then left it 
overnight. 
Only 9 was 
observed, but 2 
isomers of it, 27% 
of one and 35% of 
the other isomer. 
 
 
1H NMR and HRMS analyses show the characteristic signals for both compounds 9 and 
10, as well as some degradation of the starting material, which was expected. The yield 
for entry b is higher than that for entry a, this is also expected. The reason for that is the 
reaction time for entry b is longer than for a. Another important factor to be considered 




3.4.5 Synthesis of aldol addition product 9 and aldol condensation product 10 
with LiHMDS as the base. 
 
Scheme 9. Synthesis of aldol addition product 9 and aldol condensation product 10 with  
LiHMDS as the base. 
 
The reaction was monitored by TLC and after about 48 hours there was no difference in 
TLC tests so the reaction was stopped, worked up and analyzed. 1H NMR and HRMS 
analyses showed the characteristic signals for starting material, decomposition of it and 
benzaldehyde. Even HRMS did not show trances of compounds 9 and 10. Maybe LiHMDS 
is not strong enough or is too bulky to come close to the glycine protons.  
 
3.4.6 Synthesis of aldol addition product 9 with LDA as the base. 
 
Scheme 10. Synthesis of aldol addition product 9 with LDA as the base. 
 
TLC showed some change, but also showed starting material. As for the visible change of 
reaction mixture, it was difficult to see it, since LDA mixture was very brown. So when 
LDA was added the reaction mixture became dark brown. 1H NMR and HRMS showed 
the characteristic signals for both aldol addition product 9. 1H NMR also revealed that 
there are 2 isomers of the product which yielded about 1% of one isomer and about 8% 
of the other. So, even though the reaction time was short some of the desired product 
still formed. However, this reaction could use some improvements like increasing the 
reaction time and using a fresher LDA.  
 
3.4.7 Synthesis of aldol addition product 9 and aldol condensation product 10 
with TMP as the base. 
 
Scheme 11. Synthesis of aldol addition product 9 and aldol condensation product 10 
with TMP as the base. 
 
TLC tests during the reaction did not show much difference from starting mixture. 1H 
NMR and HRMS analyses revealed that this reaction did not work, all that was observed 
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in the spectra was starting material, degradation of it and benzaldehyde. This is probably because TMP wasn’t strong enough to take one of the glycine protons or it 
could have been that TMP is just too bulky and have problems getting to the glycine 
proton, just like LiHMDS. Or maybe TMP complex was just old and got destroyed. And 
like some of the other reactions, this one also could use some improvements.  
 
3.4.8 Synthesis of aldol addition product 12 with BuLi as the base. 
 
Scheme 12. Synthesis of aldol addition product 12 with BuLi as the base. 
 
Compound 7 was first mixed with THF and cooled down to -78oC, and then BuLi was 
added slowly with a syringe and stirred for a while. Later isobutyraldehyde was added 
with a syringe as well and left the reaction in a -78oC open cooling bath. This was so that 
the reaction would still run at -78oC for a few more hours and then automatically by 
itself go to room temperature. The reaction was left overnight under N2. 1H, 13C NMR and 
HRMS show clear characteristic signals for compound 12. Isobutyraldehyde is smaller 
than benzaldehyde in size, therefore the isopropyl group from the valine part of the bis-
lactim ether will have less influence over on which side isobutyraldehyde will bind. So, 
unless there is a condensation reaction done afterwards there is a possibility for both 
isomers. Compared to benzaldehyde which is bigger and is forced to bind on the 
opposite side of the isopropyl group. However, from 1H NMR and COSY it was 
determined that there was only 1 isomer which yielded in 10% of pure aldol addition 
product 12. 
 
3.4.9 Synthesis of aldol addition product 15 with BuLi as the base. 
 
Scheme 13. Synthesis of aldol addition product 15 with BuLi as the base. 
 
The procedure is exactly the as for other reactions. The reaction was monitored by TLC 
and after 48h there was no difference on TLC tests, so it was stopped and worked up. 1H 
NMR and HRMS analyses showed signals characteristic for compound 15, some 
unreacted starting material was also observed. 1H NMR also revealed that there are two 
isomers in the product and the total yield of them both are 54%. 
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3.4.10 Synthesis of aldol addition product 18 and condensation product 19 with 
BuLi as the base. 
 
Scheme 14. Synthesis of aldol addition product 18 and condensation product 19 with 
BuLi as the base. 
 
The same procedure and the exact same conditions were used as for the experiment that 
is described in section 3.4.8. 1H NMR and HRMS analyses revealed that there was still 
some unreacted starting material left, something of compounds 18 and some trace 
amounts of compound 19 in HRMS. 1H NMR spectra also shows some indications that 
there are also 2 isomers with the total yield of 60%. 
 
3.4.11 Summary of aldol addition/condensation reactions. 
In all aldol addition/condensation reactions we see that the amounts of aldol addition 
products are higher than the amounts of the condensation product, and this makes 
sense since the base is most likely used up and there is no way to make the condensation 
reaction. A solution to this could be to add more of the same base used in the reaction, 
especially in those reactions where there is still some unreacted starting material left. 
That would also improve the yield altogether. Table 5 below presents a summary of all 
aldol addition/condensation reactions.  
 











A 7 Cs2CO3 Benzaldehyde r.t. 96 hours No reaction 
B 7 ktBuO/Bu
OH 





















E 7 LiHMDS Benzaldehyde -78oC 48 hours No reaction 
F 7 LDA Benzaldehyde -78oC 3 hours Total of 9% 
G  7 TMP 
complex 
Benzaldehyde  r.t. 3 hours No reaction 





I  7 BuLi Acetophenone -78oC to 
r.t. 
overnight 54% 









3.5 Alkylation reactions between bis-lactim ether and alkyl halides. 
This section will only summarize the alkylation reactions shortly since the goal of them 
was just to test if the different bases were still working, because as mentioned earlier 
some of them was quite old. Reaction conditions for alkylation with different bases were 
mostly the same, Table 6 below presents what is different and which results were 
gathered.  
 









A 7 BuLi Benzyl 
bromide 
-78oC 3 hours 63% 
B 7 LiHMDS Benzyl 
bromide 
-78oC to r.t. Overnight 3% 
C  7 LDA Benzyl 
bromide 
-78oC to r.t. Overnight  15% 
(r.t. =room temperature) 
 
From the yields in Table 6 we can see that the reaction where BuLi was used is the best. 
This can be influenced by many things, maybe LiHMDS and LDA were just old bases, 
which they were, and were mostly destroyed, while BuLi was fresher and gave better 
results. Another factor can be the size of the bases. BuLi compared to the other two are a 










































The first part of the thesis, sections 3.1-3.3, describes my work towards the synthesis of 
bis-lactim ether 7 using the Schöllkopf approach. This synthesis is also thoroughly 
described in literature. And overall, results that were obtained from the reactions, are 
what was expected, even though there were some complications in syntheses due to 
minor errors. Especially the purification of the 2,5-diketopiperazine 6. 
A number of reactions of bis-lactim ether 7 synthesis have been performed to make an 
optimization, from the results we can see that the yield ranged from 43% to 48% of pure 




Scheme 15. Summary of the synthesis of bis-lactim ether 7. 
 
In the aldol addition and condensation reactions we observed that most of the formed 
product was the aldol addition product, and that goes for all the different aldehydes and 
ketones used, and that is expected since we did not use large amounts of base. The yields 
in Table 5 show us that the best base for this type of reactions is BuLi, despite whether 
the substrate is an aldehyde or ketone. The other bases like Cs2CO3, DBU and BuOK are 
perhaps just not strong enough to take of the glycine protons. The other lithium bases, 
LiHMDS, LDA and TMP complex, were not that good either. A reaction with them either 
did not happen at all, or produced very low yields. LDA gave only 9% of aldol addition 
product 9. However, we know that the alkylation reaction of bis-lactim ether 7 should 
work, and Table 6 presents the results of those alkylation reactions. We see that 
LiHMDS and LDA work quite badly compared to BuLi, and this tells us two things. 
LiHMDS and LDA were either too old and were pretty much destroyed reagents and/or 
they were too bulky to be able to come close to the glycine protons. Scheme 16 presents 





Scheme 16. Summary of aldol addition reactions with their respective products.  
 
From analyses of the aldol addition products of reactions with benzaldehyde, 
acetophenone and benzophenone we could also observe that there were 2 isomers. 
Where one OH is in the R- and the other in the S-conformation. We were unable to purify 
these two isomers since they moved through a silica gel column at the same rate. Due to 
lack of time there was not put that much effort into purification of these isomers. 
Further work might be done by someone else in the future to purify these isomers as 
well as try to go back from substituted bis-lactim ether to ketone version of the 
molecule, as presented in Scheme 17. 
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6 Experimental section 
All reagents were purchased from Sigma Aldrich Co. and used as received. Dry DMF and 
THF was obtained from water free bottles with molecular sieves and under inert gas. All 
glassware used under inert conditions were heated in oven at 105°C overnight. Column 
chromatography was performed using silica gel 35-70 micron from Grace GmbH. 
Reactions monitored by TLC was run on 60 F254 silica gel plates and visualized with UV 
and stains.  
NMR spectra were recorded on Varian Mercury-400 plus and AscendTM 400 Bruker with 
samplecase NMR spectrometers. Chemical shift values ( ) are reported in parts per 
million (ppm) relative to chloroform. All NMR spectra were processed with MestReNova 
v8.0.1-10878. All molecular structures were made in ChemDraw Ultra 11.0. 
Progress of some experiments was also monitored by GC-MS, it was done on a Thermo 
Scientifinc Trace GC Ultra with a Thermo Scientific ITQ 1100 detector. HRMS spectra 
were recorded LTQ Orbitrap XL in positive electrospray ionization (ESI) mode. IR 
spectra were obtained on a Agilent Technologies Cary 630 FT-IR spectrometer. 
Absorptions are given in reciprocal centimetres. Microwave irradiation was in a 
Microwave synthesis reaction Monowave 300 from Anton Paar.  
 
6.1 (R)-methyl 2-(2-(tert-butoxycarbonylamino)-3-methylbutanamido)acetate 
(5) 
 
A 250 mL round bottom flask with 105 mL CH2Cl2 was cooled down on ice together with 
Boc-Val-OH (7.98 g, 36.7 mmol) and Et3N (3.73 g, 36.9 mmol), which was then closed 
and mixed. Then 4.75 mL of isobutyl chloroformate was added dropwise with a syringe 
during 30 minutes, and after that, this mixture was stirred for about 35 minutes on ice.  
At the same time in another flask, glycine methyl ester hydrochloride (4.61 g, 36.7 
mmol) and Et3N (3.74 g, 37.0 mmol) were mixed in 105 ml CH2Cl2 and stirred for 35 
minutes at room temperature. After those 35 minutes, the mixture with glycine methyl 
ester was added to the first mixture with Boc-Val-OH dropwise during 1 hour and 45 
minutes with the help of an addition funnel. After the addition was complete, the 
reaction mixture stirred for about 19 hours at room temperature and then washed with 
water (3 * 120 mL) and about 50 mL BRINE, then dried with Na2SO2 and concentrated 
under vacuum to yield 10.2 g (97%) crude. 
The crude was purified by recrystallization from cyclohexane to yield pure (R)-methyl 2-
(2-(tert-butoxycarbonylamino)-3-methylbutanamido)acetate (5) as white powder (8.02 
g, 76%). NOTE: during collection of the product after recrystallization some of it was lost 
due to a small accident, but not much was lost.  
 
1H-NMR (MeOD, 400 MHz):  0.93 (3H, d, J = 8 Hz),  0.98 (3H, d, J = 8 Hz),  1.43 (9H, d, 
J = 12 Hz),  2.19 (1H, m),  3.76 (3H, s),  3.96-4.07 (3H, m),  5.02 (1H, s),  6.47 (1H, 
s). 
13C-NMR (CDCl3, 100 MHz): Too much noise, difficult to see.  
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6.2 Synthesis of (S)-3-isopropylpiperazine-2,5-dione (6) by conventional heating 
 
(R)-methyl 2-(2-(tert-butoxycarbonylamino)-3-methylbutanamido)acetate (5) (0.99 g, 
3.43 mmol) was transferred to a round bottom flask containing 10 mL 1,2-
dichlorobenzene. A reflux system was set up; the mixture was put on stirring and heated 
to about 172oC and left it like that overnight, about 19 hours. After that, the reaction 
mixture was cooled down to about 50oC and 6 mL of TBME was added, and then cooled 
down to room temperature. Since the product was a solid and it precipitated in the 
reaction, the reaction mixture was just filtered through a sintered glass filter and 
washed with about 10 mL TBME. The resulting solid had a light-brown color and was 
left in the hood to dry at room temperature. The crude from the reaction yielded un-
pure (S)-3-isopropylpiperazine-2,5-dione (6) 0.190 g (1.22 mmol, 35%). This reaction 
was performed one more time under the same conditions and it yielded un-pure (S)-3-
isopropylpiperazine-2,5-dione (6) (0.164 g, 1.05 mmol, 31%).  
 
1H-NMR (CDCl3, 400 MHz):  0.86 (3H, d, J = 4 Hz),  0.93 (3H, d, J = 4 Hz),  2.08 (1H, 
m),  3.52 (1H, m),  3.62 and 3.80 (AB, 2H, J = 16 Hz),  7.99 (1H, s),  8.17 (1H, s). 
 
Due to low yields in both reactions, it was decided to leave the purification of (S)-3-
isopropylpiperazine-2,5-dione (6) from these reactions after it was performed with the 
assistance of a microwave. The experiment of microwave assisted synthesis of (S)-3-
isopropylpiperazine-2,5-dione (6) showed better results both in the color of the crude 
product and the yield was more than twice as much, see section 3.2.2. So it was decided 
to leave the purification of this crude product altogether.    
 
6.3 Microwave synthesis of (S)-3-isopropylpiperazine-2,5-dione (6) 
 
(R)-methyl 2-(2-(tert-butoxycarbonylamino)-3-methylbutanamido)acetate (5) (0.995 g, 
3.45 mmol) was transferred to a special G30 microwave vial with a magnetic stirring 
bar. Then 10 mL of distilled H2O was added and the vial was closed with a special lock 
designed for the microwave. The reaction was run at 150oC, 600 rpm and 15 minutes. 
After the reaction was done, the MW machine cooled the mixture down to 55 oC and it 
was taken out and it saw mixture was completely transparent. The mixture was 
transferred to a round bottom flask and set to evaporation under vacuum. Reaction 
resulted in white solid that was recrystallized from EtOH/CHCl3 (3:1) to yield (S)-3-
isopropylpiperazine-2,5-dione (6) 0.154 g (0.000986 mmol, 29%). Additional syntheses 
of (S)-3-isopropylpiperazine-2,5-dione (6) were performed the same way, but with 
different reaction conditions like time and temperature, Table 2 in section 3.2.2 




1H-NMR (CDCl3, 400 MHz):  0.97 (3H, d, J = 4 Hz),  1.04 (3H, d, J = 4 Hz),  2.21-2.29 
(1H, m),  3.72-3.75 (1H, m),  3.83 (1H, d, J = 20),  4.00 (1H, d, J = 20). 
HRMS (ESI) m/z: [M+H]+ calculated for C7H12N2O2: 156.09; Found for C7H12N2O2 + H2O: 
175.1080 
 







(S)-3-isopropylpiperazine-2,5-dione (6) (0.195 g, 1.25 mmol) was transferred to a 25 
mL round bottom flask with 10 mL CH2Cl2, a reflux system was set up and the mixture 
was set to stir. Then Et3O+BF4- (1M in methylene chloride) solution (0.75 mL, 4.04 
mmol) was added to the stirring mixture, and the reaction stirred at room temperature 
for 7 days. After that, the reaction mixture was transferred to a 20 mL NaHCO3 and 20 
mL DCM solution that was cooled down to about 5oC beforehand. During the addition of 
reaction mixture to NaHCO3:DCM solution, the pH was constantly kept at about 8-9 by 
the addition of small portions of 3M NaOH. The phases were then separated, and the 
aqueous phase extracted with DCM (2 x 25 mL). The organic phases were then collected 
together and washed with saturated NaCl solution, dries with MgSO4 and concentrated 
on a rotary evaporator. The resulting crude, yellow-brown oil was collected and saved 
without any further purification. This reaction was performed several times; the only 
difference is the amount of chemicals and reaction times that were used. Due to small 
amounts of product it was lost during the column chromatography purification.   
 
1H-NMR (CDCl3, 400 MHz):  0.88 (3H, d, J = 4 Hz),  1.00 (3H, d, J = 4 Hz),  1.27 (6H, t, J 
= 16),  2.18-2.25 (1H, m),  3.87-3.97 (3H, m, NCH and NCH2),  4.05-4.16 (4H, m). 
13C-NMR (CDCl3, 100 MHz):  170.51, 160.11, 61.97, 58.97, 50.07, 32.88, 18.80, 16.59, 
14.67. 
 





 (pure solid) 
 
(S)-3-isopropylpiperazine-2,5-dione (6) (0.250 g, 1.60 mmol) and Et3O+BF4- (pure solid) 
(1.019 g, 5.36 mmol) was transferred to a 100 mL round bottom flask with about 20 mL 
CH2Cl2, and the mixture was put to stir at room temperature. In 24 hours a TLC test was 
done to see the reaction progress, there was still a lot of starting material left. In 72 
hours the same was done and the same was observed. After a total of 144 hours a TLC 
test showed that there was no more starting material in the mixture and the reaction 
was stopped. The reaction mixture was slowly added to a cold (0-5oC) solution of 40 mL 
NaHCO3 and 40 mL CH2Cl2 that was stirring vigorously, 15 mL of 3M NaOH was also 
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added slowly at the same time to keep the pH at 8-9. The phases were then separated, 
the water phase was washed with 2x40 mL CH2Cl2. The organic phases were then 
collected and washed with BRINE, then dried with MgSO4 and concentrated on a rotary 
evaporator. The crude was then purified with a silica gel column chromatography, 
pentane:EtOAc (90:10) as the solvent which increased in polarity after a while, to yield 
0.091 g (0.43 mmol, 27%). This reaction was performed several times, the yield from 
them were 43-48% as it is presented in Table 3. 
 
1H-NMR (CDCl3, 400 MHz):  0.72 (3H, d, J = 8 Hz),  0.98 (3H, d, J = 8 Hz),  1.21-1.24 
(6H, m),  2.15-2.21 (1H, m),  3.85-3.94 (3H, m),  3.97-4.19 (4H, m). 
13C-NMR (CDCl3, 100 MHz):  164.39, 161.89, 61.10, 60.78, 46.85, 32.63, 19.11, 17.10, 
14.40 
HRMS (ESI) m/z: [M+H]+ calculated for C11H20N2O2 [M+H]+: 213.1580; Found: 213. 1593 
 
6.6 Aldol addition, condensation and alkylation of (S)-3,6-diethoxy-2-isopropyl-
2,5-dihydropyrazine (7) with different bases 
Note; the aldol addition, condensation and alkylation reactions of 7 were carried out in 
the same way, but with different agents and different results. Thus will only be 
described for one general experiment, but the results will be presented for all reactions. 
 
Bis-lactim ether 7 was mixed with reaction solvent DMF/THF, and then either left at 
room temperature or cooled down to -78oC. Then a base was added slowly with a 
syringe, and after addition the reaction mixture was allowed to stir for about 1 hour at -
78oC. Then benzaldehyde, isobutyraldehyde, acetophenone, benzophenone or benzyl 
bromide was added with a syringe slowly to the reaction mixture, and then left in the 
same cooling bath at -78oC which was open. So that the reaction would still go at -78oC 
for some hours and then heat up to room temperature overnight by itself. In the work 
up, the reaction mixture was quenched with either water/ammonia solution but mostly 
by phosphate buffer with pH 7. Then diethylether or DCM was added and mixed very 
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well and the phases were separated. The water phase was washed twice with 
diethylether or DCM (about 10-20 mL). The organic phases were then collected and 
washed with BRINE, then dried with Na2SO4, filtered and concentrated on rotary 
evaporator. The crude was then purified on a silica gel column with pentane:EtOAc 
(95:5) as the starting solvent which after a while was increased in polarity. All the 
specific conditions and results from these reactions are presented in Table 7 below. 
 
Table 7. Summary of Aldol addition, condensation and alkylation of (S)-3,6-diethoxy-2-
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1H-NMR for (9) (CDCl3, 400 MHz):  0.77 (3H, d, J = 8 Hz),  1.01 (3H, d, J = 8 Hz),  
1.25-1.38 (6H, m),  2.18-2.27 (1H, m),  3.75-3.77 (1H, t, J = 8 Hz),  4.10-4.27 (5H, 
m),  5.08 (1H, m),  7.16-7.40 (5H, m). (5H, m). 
13C-NMR for (9) (CDCl3, 100 MHz):  165.62, 161.13, 141.61, 127.89, 127.65, 126.76, 
126.66, 74.54, 61.09, 60.72, 50.48, 31.91, 19.06, 16.87, 14.40, 14.34 
HRMS for (9) (ESI) m/z: [M+H]+ calculated for C18H24N2O3 [M+Na]+: 341.1798; Found: 
341.1839 
 
1H-NMR for (12) (CDCl3, 400 MHz):  0.73 (3H, d, J = 8 Hz),  0.98 (3H, d, J = 4 Hz),  
1.03 (3H, d, J = 4 Hz),  1.04 (3H, d, J = 4 Hz),  1.21-1.33 (4H, m),  1.94-2.03 (1H, m), 
 2.22-2.30 (1H, m),  3.93-3.96 (1H, m),  4.04-4.05 (1H, m),  4.07-4.25 (5H, m). 
13C-NMR for (12) (CDCl3, 100 MHz):  165.30, 162.13, 77.57, 60.97, 60.89, 57.42, 
32.23, 31.18, 19.63, 19.45, 19.21, 19.12, 17.03, 14.50, 14.46 




1H-NMR for (15) (CDCl3, 400 MHz):  0.58 (3H, d, J = 8 Hz),  0.9 (3H, d, J = 4 Hz),  
1.13-1.36 (6H, m),  2.09-2.22(1H, m),  3.04 (1H, t, J = 8.0 Hz),  3.91-4.25 (4H, m),  
4.65 (3H, s),  7.17-7.38 (5H, m). 
13C-NMR for (15) (CDCl3, 100 MHz): No carbon specter for this molecule. 
HRMS for (15) (ESI) m/z: [M+H]+ calculated for C19H26N2O3 [M+H]+: 333.2180; Found: 
333.2166 
1H-NMR for (18) (CDCl3, 400 MHz):  0.53 (3H, d, J = 4.0 Hz),  0.81 (3H, d, J = 8.0 Hz), 
 0.87 (3H, t, J = 12.0),  1.01 (3H, t, J = 12.0),  2.00-2.08 (1H, m),  3.29 (1H, t, J = 8.0), 
 3.73-3.92 (5H, m),  4.69 (1H, d, J = 4.0),  7.07-6.68 (10H, m). 
13C-NMR for (18) (CDCl3, 100 MHz):  196.83, 164.41, 160.88, 144.31, 144.29, 137.71, 
132.51, 130.16, 128.38, 127.82, 127.75, 127.46, 127.11, 126.91, 80.75, 63.92, 61.08, 
60.94, 60.87, 31.49, 19.19, 16.86, 14.31, 13.97 


























7 Spectra of molecules 





















ABAK-13_pos #1-4 RT: 0.02-0.11 AV: 4 NL: 6.19E6
T: FTMS + p ESI Full ms [100.00-450.00]
































































7.6 ((5S)-3,6-diethoxy-5-isopropyl-2,5-dihydropyrazin-2-yl)(phenyl)methanol (9) 
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7.7 1-((5S)-3,6-diethoxy-5-isopropyl-2,5-dihydropyrazin-2-yl)-2-methylpropan-
1-ol (12) 
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7.8 1-((5S)-3,6-diethoxy-5-isopropyl-2,5-dihydropyrazin-2-yl)-1-phenylethanol 
(15) 
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7.9 ((5S)-3,6-diethoxy-5-isopropyl-2,5-dihydropyrazin-2-yl)diphenylmethanol 
(18) 
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